Clinical Trial Update: Study of ZG005 in Patients With Advanced Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ZG005 in patients with advanced solid tumors is currently recruiting in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ZG005

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Advanced Solid Tumor | Phase 2 | Status: RECRUITING